GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress - Seite 2

GE HealthCare’s novel radiation therapy solutions, and recent acquisition of the MIM Software portfolio, are designed to reshape the oncology experience around the needs of providers and their patients across the cancer care continuum:

Introducing Revolution RT

As healthcare systems around the world experience growing volumes of radiation therapy (RT) patients, providers are looking for a CT simulator that enables precision simulation while reducing workflow complexity, with the goal of expediated patient care.^iv

GE HealthCare designed its new Revolution RTⁱ with a wide-bore CT platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities to accommodate more patients, and create a more streamlined standard of care. Revolution RT includes precision radiotherapy simulation that will help enable more accurate imaging, while improving workflow and efficiency, and using deep learning technology to help image the patient with accuracy.

Updated Intelligent Radiation Therapy (iRT)

At ESTRO 2024, GE HealthCare will also be showcasing the newly updated iRT platform, which was originally launched at ESTRO 2023. This innovative solution enables greater interoperability, connectivity, and efficiency throughout the entirety of the radiation oncology care continuum and includes key features such as an integrated workflow that connects various applications into an intuitive single interface, multi-vendor interoperability, seamless data transfer and task automation, and a catalog of RT applications from both GE HealthCare and third parties.

The company is unveiling multiple updates to the iRT platform, which highlight its vendor-agnostic ecosystem:

• MR Direct (with Spectronic Medical): Spectronic Medical’s application, which is integrated into the updated iRT, uses AI to convert MR simulation images into an equivalent CT image that can be used for RT dose calculation.
• Simplified Planning (with MIM): Advance interoperability with automated context launching to simplify pre-treatment planning steps including image viewing, segmentation, and fusion.
• InstaPlan (with RaySearch): A novel approach to treatment plan creation while the patient is still on the simulation table. This is a paradigm shift that can potentially reduce the time between simulation and first radiation dose. GE HealthCare’s collaboration with RaySearch will bring further innovation in simulation and treatment planning workflows to support advancements in Photon, Electron, Particle, and Brachy therapies.
• Personalization: The newly enhanced version of iRT is updated to allow user-enabled personalization, analytics, and notification modules.

“The key to better patient outcomes in oncology care requires solutions that simplify and shorten an incredibly complex workflow for providers, as well as personalize the care pathway for patients, in order to ensure more effective care for each individual,” said Dr. Ben Newton, general manager, Oncology at GE HealthCare. “GE HealthCare worked closely with clinicians globally to develop the iRT platform which streamlines the radiation therapy pathway by connecting disparate multi-vendor application systems, creating a vendor-agnostic ecosystem and harnessing the power of AI to potentially reduce the critical time between treatment planning and first treatment.”